Viewing StudyNCT00005096



Ignite Creation Date: 2024-05-05 @ 9:27 AM
Last Modification Date: 2024-10-26 @ 9:04 AM
Study NCT ID: NCT00005096
Status: COMPLETED
Last Update Posted: 2017-07-14
First Post: 2000-04-06

Brief Title: Docetaxel in Treating Patients With Stage II or Stage III Prostate Cancer
Sponsor:
Organization: Dana-Farber Cancer Institute